We represented Axial Healthcare, Inc., a leading pain care solutions company, in its Series B round of financing led by Oak HC/FT, a venture growth-equity fund investing in healthcare services. The company initially secured $16.5 million, which will be used to further drive expansion of Axial’s suite of pain management capabilities, including a cloud-based,provider decision-support platform for pain treatment. The company has an option to raise an additional $1.25 million for aggregate proceeds of $17.75 million. Previous investors .406 Ventures, BlueCross BlueShield Venture Partners, Highmark Ventures, BlueCross BlueShield of Tennessee and Sandbox Advantage Fund, also participated in this round of financing.
Axial Healthcare Secures Series B Funding
You Also May Be Interested In:
Representation of Tennessee Community Bank Holdings, Inc., the parent company for Community Bank & Trust located in Ashland City, Tennessee, in its definitive agreement to sell to Reliant Bancorp, Inc. (Nasdaq: RBNC) for $37 million in an approximately 50% stock and 50% cash transaction.
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.